Associates Of Sterling Podiatry Podiatrist Medicare: Medicare Enrolled Practice Location: 4507 N Sterling Ave, Suite 102, Peoria, IL 61615 Phone: 309-272-7322 Fax: 309-272-2251 |
Dr. Donald Joe Sheller, DPM Podiatrist - Foot & Ankle Surgery Medicare: May Accept Medicare Assignments Practice Location: 3827 N Prospect Rd, Peoria, IL 61616 Phone: 309-686-1000 Fax: 309-686-8174 |
Leandre Kennedy, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 2802 W Gilbert Ave, Peoria, IL 61604 Phone: 612-437-7425 |
News Archive
While today many medical-imaging needs are being met with traditional vacuum tube-based technology, large segments of the X-ray-imaging market are poorly served, and there is widespread demand for both performance improvements and cost reductions.
Climate change threatens prospects for further progress in cancer prevention and control, increasing exposure to cancer risk factors and impacting access to cancer care, according to a new commentary by scientists from the American Cancer Society and Harvard T. H. Chan School of Public Health.
In people with high cholesterol levels, the fat that is built up in the artery walls narrows the arteries causing a condition called atherosclerosis. A study published on 19th June in the European Heart Journal has found the likelihood of a vaccine that can immunize humans having atherosclerosis, subsequent to successful outcomes in a mouse model study. At present, phase I clinical trial has begun in patients to see the possibility of translating the study findings to humans.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, and Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of patients with refractory angina resulting from diffuse coronary artery disease, today announced that the boards of directors of both companies have approved a definitive agreement under which CryoLife will acquire all of the outstanding shares of Cardiogenesis for $0.457 per share.
› Verified 5 days ago